| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |